Taro Pharmaceutical Industries Ltd
Taro Pharmaceutical Industries Lt.../ IL0010827181 /
TARO
|
09/05/2024 22:10:00
|
Var.
+0.13
|
Volume |
Denaro22:19:55 |
Lettera22:19:55 |
Capitalizzazione di mercato |
Dividend Y. |
Rapporto P/E |
|
42.41USD
|
+0.31%
|
22,257
Fatturato: 538,662.80 |
42.21Quantità in denaro: 100 |
42.41Quantità in lettera: 100 |
1.58 bill.USD |
- |
57.63 |
Descrizione business
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| Uday Baldota |
| Consiglio di amministrazione |
| William J. Coote, Vikash Agarwal, Avi Avramoff, Victoria Chester, Anthony Dolan, Moshe Gavrilov, Nivaran Kapur, David Kinzelberg, Karen Lowney, Barb Pimentel, Hagai Reingold, Michele Visosky, Erik Zwicker |
| Consiglio di sorveglianza |
| Dilip Shanghvi, Abhay Gandhi, Uday Baldota, Linda Benshoshan, James Kedrowski, Dr. Robert Stein, Sudhir Valia |
Dati aziendali
| Name: |
Taro Pharmaceutical Industrie |
| Indirizzo: |
14 Hakitor Street, Haifa Bay,Haifa 2624761 |
| Telefono: |
+972 4 847 5700 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.taro.com/ |
| Industria: |
Healthcare |
| Settore: |
Pharmaceutical Industry |
| Sub settore: |
Pharmaceuticals |
| Fine dell'anno finanziario: |
30/03 |
| Flottante libero: |
- |
| Data dell'IPO: |
01/01/1961 |
